Overview

Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT

Status:
RECRUITING
Trial end date:
2026-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to collect data about how Rhopressa affects IOP in patients who have had an SLT procedure in both eyes.
Phase:
PHASE4
Details
Lead Sponsor:
East Coast Institute for Research
Collaborators:
Alcon, a Novartis Company
Florida Eye Specialists
Treatments:
Lubricant Eye Drops